These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 2521866)

  • 1. Embryo quality and uterine receptivity in in-vitro fertilization cycles with or without agonists of gonadotrophin-releasing hormone.
    Testart J; Forman R; Belaisch-Allart J; Volante M; Hazout A; Strubb N; Frydman R
    Hum Reprod; 1989 Feb; 4(2):198-201. PubMed ID: 2521866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of different stimulation treatments on oocyte characteristics and in-vitro fertilizing ability.
    Testart J; Belaisch-Allart J; Forman R; Gazengel A; Strubb N; Hazout A; Frydman R
    Hum Reprod; 1989 Feb; 4(2):192-7. PubMed ID: 2521865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depot versus daily administration of gonadotrophin releasing hormone agonist protocols for pituitary desensitization in assisted reproduction cycles.
    Albuquerque LE; Saconato H; Maciel MC
    Cochrane Database Syst Rev; 2002; (3):CD002808. PubMed ID: 12137658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of gonadotrophin-releasing hormone agonists (GnRHa) on follicle and oocyte quality.
    Testart J; Lefevre B; Gougeon A
    Hum Reprod; 1993 Apr; 8(4):511-8. PubMed ID: 8501176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term evaluation of implantation of fresh and cryopreserved human embryos following ovarian stimulation with buserelin acetate-human menopausal gonadotrophin (HMG) or clomiphene citrate-HMG.
    Van der Elst J; Van den Abbeel E; Camus M; Smitz J; Devroey P; Van Steirteghem A
    Hum Reprod; 1996 Oct; 11(10):2097-106. PubMed ID: 8943509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gonadotrophin-releasing hormone agonist protocols for pituitary suppression in assisted reproduction.
    Maheshwari A; Gibreel A; Siristatidis CS; Bhattacharya S
    Cochrane Database Syst Rev; 2011 Aug; (8):CD006919. PubMed ID: 21833958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of gonadotropin releasing hormone agonist (GnRHa) in good responders undergoing repeat in vitro fertilization/embryo transfer (IVF/ET).
    Segars JH; Hill GA; Bryan SH; Herbert CM; Osteen KG; Rogers BJ; Wentz AC
    J In Vitro Fert Embryo Transf; 1990 Dec; 7(6):327-31. PubMed ID: 2127603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormonal stimulation for in vitro fertilization: a comparison of fertilization rates and cytogenetic findings in unfertilized oocytes.
    De Sutter P; Dhont M; Vandekerckhove D
    J Assist Reprod Genet; 1992 Jun; 9(3):254-8. PubMed ID: 1525457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of long-acting gonadotropin-releasing hormone agonist (GnRH-a; decapeptyl) and gonadotropins versus short-acting GnRH-a (buserelin) and gonadotropins before and during ovarian stimulation for in vitro fertilization (IVF).
    Gonen Y; Dirnfeld M; Goldman S; Koifman M; Abramovici H
    J In Vitro Fert Embryo Transf; 1991 Oct; 8(5):254-9. PubMed ID: 1836810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is the retrieval of high numbers of oocytes desirable in patients treated with gonadotrophin-releasing hormone analogues (GnRHa) and gonadotrophins?
    Pellicer A; Ruiz A; Castellvi RM; Calatayud C; Ruiz M; Tarin JJ; Miró F; Bonilla-Musoles F
    Hum Reprod; 1989 Jul; 4(5):536-40. PubMed ID: 2507575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of clinical efficacy of long- versus short-acting gonadotrophin-releasing hormone agonists for pituitary down regulation in
    Umemmuo MU; Efetie ER; Agboghoroma CO; Momoh JA; Ikechebelu JI
    Niger Postgrad Med J; 2020; 27(3):171-176. PubMed ID: 32687115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of long- and short-acting forms of gonadotrophin-releasing hormone analogues in women undergoing oocyte donation.
    Neuspiller F; Levy M; Remohí J; Ruiz A; Simón C; Pellicer A
    Hum Reprod; 1998 May; 13(5):1148-51. PubMed ID: 9647536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression with gonadotropin-releasing hormone analogues prior to stimulation with gonadotropins: comparison of three protocols.
    Lipitz S; Ben-Rafael Z; Dor J; Shalev J; Elenbogen A; Levran D; Serr DM; Mashiach S
    Gynecol Obstet Invest; 1989; 28(1):31-4. PubMed ID: 2528497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of Alarelin and Triptorelin in the long-protocol ovulation induction in in vitro fertilization and embryo transfer].
    Duan JL; Jiang YH; Liu Y; Zeng QF; Huang YD
    Zhonghua Nan Ke Xue; 2010 Jul; 16(7):611-4. PubMed ID: 20873594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes from ovarian hyperstimulation following the sole administration of gonadotrophin-releasing hormone agonist in the context of in vitro fertilization: report of two cases and review of the literature.
    Pinto E; Pinelo S; Osório M; Ferreira C; Serra H; Pires I; Barbosa A; Figueiredo H; Felgueira E; Tavares A
    Gynecol Endocrinol; 2012 Jul; 28(7):545-8. PubMed ID: 22439899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of clinical efficacy between a single administration of long-acting gonadotrophin-releasing hormone agonist (GnRHa) and daily administrations of short-acting GnRHa in in vitro fertilization-embryo transfer cycles.
    Cheon KW; Song SJ; Choi BC; Lee SC; Lee HB; Yu SY; Yoo KJ
    J Korean Med Sci; 2008 Aug; 23(4):662-6. PubMed ID: 18756054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of buserelin and nafarelin in IVF cycles and in subsequent frozen-thawed embryo transfer cycles.
    Simberg N; Tulppala M; Husa LM; Tiitinen A
    Acta Obstet Gynecol Scand; 1998 Sep; 77(8):854-9. PubMed ID: 9776601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical evaluation of three different gonadotrophin-releasing hormone analogues in an IVF programme: a prospective study.
    El-Nemr A; Bhide M; Khalifa Y; Al-Mizyen E; Gillott C; Lower AM; Al-Shawaf T; Grudzinskas JG
    Eur J Obstet Gynecol Reprod Biol; 2002 Jul; 103(2):140-5. PubMed ID: 12069736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The risk of ectopic pregnancy following GnRH agonist triggering compared with hCG triggering in GnRH antagonist IVF cycles.
    Sahin S; Ozay A; Ergin E; Turkgeldi L; Kürüm E; Ozornek H
    Arch Gynecol Obstet; 2015 Jan; 291(1):185-91. PubMed ID: 25078054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective randomized comparison of two gonadotrophin-releasing hormone agonists, nafarelin acetate and buserelin acetate, in in-vitro fertilization-embryo transfer.
    Goldman JA; Dicker D; Feldberg D; Ashkenazi J; Voliowich I
    Hum Reprod; 1994 Feb; 9(2):226-8. PubMed ID: 8027276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.